Código QR (código de barras bidimensional)

Recent Advances in the Management of EGFR-Mutated Advanced Non-Small Cell Lung Cancer—A Narrative Review

The treatment landscape for EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) has evolved significantly with multiple combination regimens demonstrating superiority over single agent Osimertinib over the past two years. Recent trials such as FLAURA2 and MARIPOSA have explored intensified f...

ver descrição completa

Na minha lista:
Principais autores: Prabhat Gautam Roy, Davida Reingold, Neha Pathak, Saurav Verma, Aarushi Gupta, Nicholas Meti, Consolacion Molto, Prabhat Singh Malik, Geordie Linford, Abhenil Mittal
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2025-08-01
coleção:Current Oncology
Assuntos:
EGFR
Osimertinib
chemotherapy
Amivantamab
Lazertinib
Acesso em linha:https://www.mdpi.com/1718-7729/32/8/448
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados